Variant report
Variant | esv2421683 |
---|---|
Chromosome Location | chr6:160628905-160638076 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-LPA-7 | chr6:160638046-160638530 | NONHSAT115898 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs3861973 | chr6:160628905-160628906 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs567505335 | chr6:160628915-160628916 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs535342454 | chr6:160628954-160628955 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs565170846 | chr6:160628964-160628965 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs554835084 | chr6:160628977-160628978 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs538758507 | chr6:160628978-160628979 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs138390022 | chr6:160629004-160629005 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs73600458 | chr6:160629007-160629008 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs545074898 | chr6:160629088-160629089 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs377191881 | chr6:160629140-160629141 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs575003444 | chr6:160629151-160629152 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs79252613 | chr6:160629160-160629161 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs142977190 | chr6:160629182-160629183 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs191432464 | chr6:160629192-160629193 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs540494530 | chr6:160629195-160629196 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs181563625 | chr6:160629223-160629224 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs541796733 | chr6:160629229-160629230 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs560650306 | chr6:160629336-160629337 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs528230806 | chr6:160629346-160629347 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs148015788 | chr6:160629355-160629356 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs557070947 | chr6:160629373-160629374 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs551493431 | chr6:160629408-160629409 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs685217 | chr6:160629442-160629443 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs530428769 | chr6:160629480-160629481 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs146130886 | chr6:160629528-160629529 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs550507638 | chr6:160629593-160629594 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs187026216 | chr6:160629596-160629597 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs536518272 | chr6:160629635-160629636 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs546416968 | chr6:160629645-160629646 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs566312901 | chr6:160629703-160629704 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs538785312 | chr6:160629719-160629720 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs34570321 | chr6:160629760-160629761 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs558620754 | chr6:160629771-160629772 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs75007526 | chr6:160629772-160629773 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs191909090 | chr6:160629808-160629809 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs537869446 | chr6:160629809-160629810 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs554923482 | chr6:160629824-160629825 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs3127604 | chr6:160629825-160629826 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs77941231 | chr6:160629829-160629830 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs540908795 | chr6:160629858-160629859 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs560708855 | chr6:160629866-160629867 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs368974074 | chr6:160629879-160629880 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs577511979 | chr6:160629885-160629886 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs556866 | chr6:160629960-160629961 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs144676173 | chr6:160629990-160629991 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs183389903 | chr6:160630004-160630005 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs556984 | chr6:160630005-160630006 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs538220071 | chr6:160630013-160630014 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs3101820 | chr6:160630020-160630021 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs9457863 | chr6:160630041-160630042 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Ependymoma | 16718352 | CNVD |
Gastric cancer | 17908304 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Developmental delay | 19490664 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Leukemia | 18688285 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Breast cancer | 17850661 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 20556506 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Developmental delay | 21147756 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Developmental delay | 19459884 | CNVD |
Hearing loss | 19459884 | CNVD |
Microcephaly | 19459884 | CNVD |
Coronary artery disease | 17160897 | CNVD |
Chordoma | 18071362 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Multiple myeloma | 17550852 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:160626800-160639800 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
2 | chr6:160635400-160636000 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |
3 | chr6:160635800-160639800 | Weak transcription | Pancreas | Pancrea |
4 | chr6:160636000-160636800 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
5 | chr6:160636200-160636400 | Enhancers | Osteobl | bone |
6 | chr6:160636600-160638400 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
7 | chr6:160636800-160637000 | Enhancers | H1 Cell Line | embryonic stem cell |
8 | chr6:160636800-160637000 | Enhancers | Fetal Muscle Leg | muscle |
9 | chr6:160636800-160637200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
10 | chr6:160636800-160637200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
11 | chr6:160636800-160637200 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
12 | chr6:160637000-160637200 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
13 | chr6:160637000-160637400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
14 | chr6:160637000-160639000 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
15 | chr6:160637200-160637400 | Weak transcription | H1 Cell Line | embryonic stem cell |
16 | chr6:160637200-160637400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
17 | chr6:160637200-160638200 | Weak transcription | Fetal Muscle Leg | muscle |
18 | chr6:160637200-160639600 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
19 | chr6:160637200-160639800 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
20 | chr6:160637400-160642200 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
21 | chr6:160637400-160642800 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |